InvestorsHub Logo
Followers 94
Posts 9997
Boards Moderated 0
Alias Born 03/21/2013

Re: None

Saturday, 08/01/2020 3:31:08 PM

Saturday, August 01, 2020 3:31:08 PM

Post# of 27557
”iBio currently anticipates that data from the preclinical immunization studies of its two COVID-19 vaccine candidates, IBIO-200 and IBIO-201, which are being conducted at Texas A&M University System laboratories, will be available in Q3-2020.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News